Melanie Taziaux

Liege, WAL, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Authors' reply to L. Kiesel et al.

Authors' reply to L. Kiesel et al.

Journal: Maturitas

Published: July 15, 2026

Estetrol (E4) for the treatment of moderate to severe vasomotor symptoms in postmenopausal women - Efficacy and safety results from the phase 3 E4COMFORT I multicenter, placebo-controlled study.

Estetrol (E4) for the treatment of moderate to severe vasomotor symptoms in postmenopausal women - Efficacy and safety results from the phase 3 E4COMFORT I multicenter, placebo-controlled study.

Journal: Maturitas

Published: December 19, 2025

Estetrol for the treatment of moderate to severe vasomotor symptoms in postmenopausal women: The design of the E4COMFORT I and II trials.

Estetrol for the treatment of moderate to severe vasomotor symptoms in postmenopausal women: The design of the E4COMFORT I and II trials.

Journal: Maturitas

Published: August 22, 2025

Low thrombin generation in postmenopausal women using estetrol.

Low thrombin generation in postmenopausal women using estetrol.

Journal: Climacteric : the journal of the International Menopause Society

Published: January 19, 2024

Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment.

Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment.

Journal: International journal of molecular sciences

Published: May 03, 2023

A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2-vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life.

A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2-vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life.

Journal: Menopause (New York, N.Y.)

Published: February 22, 2023

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy.

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy.

Journal: Przeglad menopauzalny = Menopause review

Published: November 27, 2022

Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women.

Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women.

Journal: Climacteric : the journal of the International Menopause Society

Published: November 18, 2022

Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer.

Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer.

Journal: Cancers

Published: March 25, 2021

A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety.

A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety.

Journal: Menopause (New York, N.Y.)

Published: May 08, 2020

Role for the membrane estrogen receptor alpha in the sexual differentiation of the brain.

Role for the membrane estrogen receptor alpha in the sexual differentiation of the brain.

Journal: The European journal of neuroscience

Published: March 28, 2019

Age-related changes in the morphology of tanycytes in the human female infundibular nucleus/median eminence.

Age-related changes in the morphology of tanycytes in the human female infundibular nucleus/median eminence.

Journal: Journal of neuroendocrinology

Published: September 19, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026